# EDGAR Filing Document

**Accession Number:** 0001428336
**File Stem:** 0001428336-26-000034
**Filing Date:** 2026-6
**Character Count:** 7152
**Document Hash:** f0a7f3202624f6da8ac73f015d9488d0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001428336-26-000034.hdr.sgml**: 20260626

**ACCESSION NUMBER**: 0001428336-26-000034

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20260625

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260626

**DATE AS OF CHANGE**: 20260626

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEALTHEQUITY, INC.
- **CENTRAL INDEX KEY:** 0001428336
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36568
- **FILM NUMBER:** 261129253

**BUSINESS ADDRESS:**
- **STREET 1:** 15 WEST SCENIC POINTE DRIVE
- **STREET 2:** SUITE 100
- **CITY:** DRAPER
- **STATE:** UT
- **ZIP:** 84020
- **BUSINESS PHONE:** 801-727-1000

**MAIL ADDRESS:**
- **STREET 1:** 15 WEST SCENIC POINTE DRIVE
- **STREET 2:** SUITE 100
- **CITY:** DRAPER
- **STATE:** UT
- **ZIP:** 84020

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHEQUITY INC
- **DATE OF NAME CHANGE:** 20080227

?xml version='1.0' encoding='ASCII'? hqy-20260625

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of**

**The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported)**

**June 25, 2026** 

**HEALTHEQUITY, INC.**<br>

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-36568** | **52-2383166** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(Commission File Number)** | **(I.R.S. Employer**<br>**Identification Number)** |

---

**15 West Scenic Pointe Drive** 

**Suite 100** 

**Draper, Utah 84020** 

**(801) 727-1000** 

**(Address, including Zip Code, and Telephone Number, including Area Code, of Registrant's Principal Executive Offices)**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, par value $0.0001 per share | HQY | The NASDAQ Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07&nbsp;&nbsp;&nbsp;&nbsp;Submission of Matters to a Vote of Security Holders.**

On June 25, 2026, the Company held its 2026 Annual Meeting. As of the close of business on May 6, 2026, the record date for the Annual Meeting, 83,830,457 shares of common stock of the Company were issued and outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, the stockholders voted on five proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on May 13, 2026. Stockholders approved each of the proposals presented for a vote. The tables below set forth the number of votes cast for and against, and the number of abstentions or broker non-votes, for each matter voted upon by the Company's stockholders.

*Proposal 1.* The election of ten directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| Robert Selander | 74453187 | 1442014 | 35205 | 3822795 |
| Scott Cutler | 75542815 | 353789 | 33802 | 3822795 |
| Stephen Neeleman, M.D. | 75032571 | 864875 | 32960 | 3822795 |
| Adrian Dillon | 74828471 | 1066059 | 35876 | 3822795 |
| Evelyn Dilsaver | 74762646 | 1131196 | 36564 | 3822795 |
| William Gassen | 75701238 | 193566 | 35602 | 3822795 |
| Debra McCowan | 74683289 | 1209511 | 37606 | 3822795 |
| Rajesh Natarajan | 75770615 | 124053 | 35738 | 3822795 |
| Stuart Parker | 75662488 | 231609 | 36309 | 3822795 |
| Gayle Wellborn | 75005354 | 811661 | 113391 | 3822795 |

---

*Proposal 2.* The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2027. There were no broker non-votes for this proposal.

---

| | | |
|:---|:---|:---|
| **For** | **Against** | **Abstain** |
| 79,249,985 | 449,600 | 53,616 |

---

*Proposal 3.* The approval, on a non-binding, advisory basis, of the fiscal 2026 compensation paid to the Company's named executive officers.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 74,032,348 | 1,852,931 | 45,127 | 3,822,795 |

---

*Proposal 4.* The approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 75,717,841 | 190,964 | 21,601 | 3,822,795 |

---

*Proposal 5.* The approval of the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 73,514,259 | 2,366,900 | 49,247 | 3,822,795 |

---

**Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits**

(d) Exhibits

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **HEALTHEQUITY, INC.** | **HEALTHEQUITY, INC.** |
| Date: June 26, 2026 | By: | /s/ James Lucania |
|  | Name: | James Lucania |
|  | Title: | Executive Vice President and Chief Financial Officer |

---